Search
for

    Sort by

    Research 91–120 of 213

    1. TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice Brain Research Bulletin · 2020 · 5 citations
    2. Skin Elsevier eBooks · 2011 · 2 citations
    3. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    4. Risks and side effects in the medical management of benign prostatic hyperplasia Prostate International · 2023 · 26 citations
    5. The association of medications and supplements with human male reproductive health: a systematic review Fertility and Sterility · 2023 · 4 citations
    6. Sex Differences in Reaction to Chronic Unpredictable Stress in the House Mouse (<em>Mus m. musculus</em>) of Wild Origin Preprints.org · 2025
    7. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism Clinical Endocrinology · 2021 · 39 citations
    8. Natural Compound Isoliensinine Inhibits Stress-Induced Hair Greying by Blocking β2-Adrenoceptor Journal of clinical pharmacy and therapeutics · 2023
    9. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician BJU international · 2004 · 98 citations
    10. Cognitive and mood side effects of lower urinary tract medication Expert Opinion on Drug Safety · 2019 · 20 citations
    11. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    12. Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition? Der Urologe · 2019 · 3 citations
    13. Androgen-induced norepinephrine release in male accessory sex organ smooth muscle growth and differentiation 2019
    14. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    15. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    16. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    17. Floppy Iris Syndrome Essentials in ophthalmology · 2022
    18. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia European urology. Supplement · 2009 · 10 citations
    19. Lower Urinary Tract Symptoms: What’s New in Medical Treatment? European urology focus · 2018 · 22 citations
    20. THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH 2019
    21. Reprogramming of human keratinocytes into functional cardiomyocytes Italian Journal of Anatomy and Embryology · 2026
    22. Potential Medical Uses of Cannabigerol: A Brief Overview Elsevier eBooks · 2017 · 14 citations
    23. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    24. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    25. Steroid 5α-reductase inhibition by polymethoxyflavones 한국응용생명화학회지 · 2013 · 6 citations
    26. Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product Acta Chromatographica · 2019 · 4 citations
    27. Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method 2012 · 3 citations
    28. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    29. Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride Journal of Medicinal Food · 2011 · 8 citations
    30. Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations Analytical Chemistry Research · 2014 · 26 citations